Panther® Scalable Solutions

    Scalable growth today and tomorrow

    Panther Scalable Solutions allows you to expand your testing menu while adding on flexibility, capacity and walkaway time.

    Choose

    Select from a broad menu of Aptima® and Panther Fusion® assays to run on scalable automation that meets your needs today and supports future growth.

    Build

    The Panther system serves as the foundation of our automation with the option to add on: the Panther Fusion module, Panther Plus, Panther Link and Panther Trax.

    Grow

    Panther Scalable Solutions provides an economical and scalable path to your lab’s growth today and into the future.

    Consolidate your assay menu

    The Aptima and Panther Fusion assays help guide patient care and enable early detection. With a menu and pipeline of world-class assays you can consolidate your molecular testing today and meet your lab’s growing needs tomorrow.

    21

    Assays Available

    10

    More in Development

    1

    Scalable Platform

    Assay Menu

    Women's Health

    CT/NG

    Mycoplasma genitalium 

    Trichomonas vaginalis

    Bacterial vaginosis

    Candida vaginitis/
    Trichomonas vaginalis

    HSV 1 & 2

    HPV

    HPV 16 18/45

    Zika Virus*

    GBS

    M. gen macrolide resistance

    Chlamydia trachomatis

    Neisseria gonorrhoeae

     

    Infectious Disease

    HIV-1 Quant Dx 

    HCV Quant Dx

    HBV Quant

    CMV Quant

    Flu A/B/RSV

    Paraflu

    AdV/hMPV/RV

    SARS-CoV-2*

    SARS-CoV-2/Flu A/B*

    SARS-CoV-2/Flu A/B/RSV

    GI Bacterial

    GI Extended Bacterial

    GI Viral

    GI Parasite

    EBV

    BKV

    C. Difficile

    What will you build?

    Panther® System

    The foundation for assay consolidation, future scalability and growth
    Add the Panther system to your lab and the capability to consolidate menu on a fully automated system, load samples in any order at any time, eliminate batch constraints and decrease turnaround time.

    Placeholder image

    Panther Fusion® System

    Flexibility, capacity and expanded menu, plus the ability to run laboratory developed tests.

    Add on the power to run real-time PCR, TMA and RT-TMA assays on a single, fully automated platform. The Panther Fusion® module enables you to consolidate testing, increase walkaway time and enhance flexibility.

    Placeholder image

    Panther® Plus

    Increased capacity, walkaway time and throughput in 24 hours

    Add on capacity with the MTU expansion module and gain the ability to plumb liquid waste and continuously dispose of fluids/wastes.

    Placeholder image

    Panther® Link

    Virtually connected Panther systems share information and monitor from a centralized dashboard

    Add on freedom by virtually connecting multiple Panther instruments, giving you the ability to share inventories, reagents and results while monitoring your entire fleet from a core location.

    Placeholder image

    Panther® Trax

    Physically connected Panther systems grow testing volumes without increasing staff

    Add on a track system that enables sample to storage automation, giving your molecular lab the potential to grow as you grow.

    Placeholder image
    * The Aptima SARS-CoV-2, Aptima Zika Virus, Aptima SARS-CoV-2/Flu and Panther Fusion SARS-CoV-2 assays have not been FDA cleared or approved: These tests have been authorized by FDA under an EUA for use by authorized laboratories; The Aptima and Panther Fusion SARS-CoV-2 assays have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; The Aptima Zika Virus assay has been authorized only for the detection of nucleic acid from Zika virus, not for any other viruses or pathogens; The Aptima SARS-CoV-2/Flu assay  has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, influenza B virus, and not for any other viruses or pathogens. The Aptima SARS-CoV-2, Panther Fusion SARS-CoV-2, and Aptima SARS-CoV-2/Flu assays are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. The Aptima Zika assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
    † In Development and not for sale
     

    Panther® Scalable Solutions

    Scalable growth today and tomorrow

    Panther Scalable Solutions allows you to expand your testing menu while adding on flexibility, capacity and walkaway time.

    Choose

    Select from a broad menu of Aptima® and Panther Fusion® assays to run on scalable automation that meets your needs today and supports future growth.

    Build

    The Panther® system serves as the foundation of our automation with the option to add on: the Panther Fusion® module, Panther® Plus, Panther® Link and Panther® Trax.

    Grow

    Panther Scalable Solutions provides an economical and scalable path to your lab’s growth today and into the future.

    Consolidate your assay menu

    The Aptima® and Panther Fusion® assays help guide patient care and enable early detection. With a menu and pipeline of world-class assays you can consolidate your molecular testing today and meet your lab’s growing needs tomorrow.

    24

    Assays Available

    5

    More in Development

    1

    Scalable Platform

    Assay Menu

    Women's Health

    Infectious Disease

    HIV-1 Quant Dx 

    HCV Quant Dx

    HBV Quant

    Flu A/B/RSV

    Paraflu

    AdV/hMPV/RV

    Bordetella

    MRSA

    SARS-CoV-2*

    SARS-CoV-2/Flu A/B*

    CMV

    EBV

    BKV

    SARS-CoV-2/Flu A/B/RSV

    GI Bacterial

    GI Extended Bacterial

    GI Viral

    GI Parasite

    What will you build?

    Panther® System

    The foundation for assay consolidation, future scalability and growth
    Add the Panther system to your lab and the capability to consolidate menu on a fully automated system, load samples in any order at any time, eliminate batch constraints and decrease turnaround time.

    Placeholder image

    Panther Fusion® System

    Flexibility, capacity and expanded menu, plus the ability to run laboratory developed tests.

    Add on the power to run real-time PCR, TMA and RT-TMA assays on a single, fully automated platform. The Panther Fusion® module enables you to consolidate testing, increase walkaway time and enhance flexibility.

    Placeholder image

    Panther® Plus

    Increased capacity, walkaway time and throughput in 24 hours

    Add on capacity with the MTU expansion module and gain the ability to plumb liquid waste and continuously dispose of fluids/wastes.

    Placeholder image

    Panther® Link

    Virtually connected Panther systems share information and monitor from a centralized dashboard

    Add on freedom by virtually connecting multiple Panther instruments, giving you the ability to share inventories, reagents and results while monitoring your entire fleet from a core location.

    Placeholder image

    Panther® Trax

    Physically connected Panther systems grow testing volumes without increasing staff

    Add on a track system that enables sample to storage automation, giving your molecular lab the potential to grow as you grow.

    Placeholder image
    * The Aptima SARS-CoV-2, Aptima Zika Virus, Aptima SARS-CoV-2/Flu and Panther Fusion SARS-CoV-2 assays have not been FDA cleared or approved: These tests have been authorized by FDA under an EUA for use by authorized laboratories; The Aptima and Panther Fusion SARS-CoV-2 assays have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; The Aptima Zika Virus assay has been authorized only for the detection of nucleic acid from Zika virus, not for any other viruses or pathogens; The Aptima SARS-CoV-2/Flu assay  has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, influenza B virus, and not for any other viruses or pathogens. The Aptima SARS-CoV-2, Panther Fusion SARS-CoV-2, and Aptima SARS-CoV-2/Flu assays are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. The Aptima Zika assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
    † In Development and not for sale